We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 31 JULY 2015
Third Circuit Extends Actavis To Reverse Settlement Agreements Involving Non-Cash Consideration
McDermott Will & Emery
The plaintiffs are direct purchasers of Lamictal, a brand-name drug used to treat epilepsy and bipolar disorder, from defendant GlaxoSmithKline (GSK).
United StatesIntellectual Property








